The latest quarterly R&D expense is $10.46 Million with a QoQ Growth of -36.89%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
Q2 FY2026 (2026-06-30).
Reported quarterly R&D expense; no daily interpolation. Q2 FY2026 (2026-06-30): $10.46M.
$10.46M
$10.46 Million
Q2 FY2026 · 2026-06-30
-36.89%
vs. $16.57M prior quarter
12
Quarters of data available
| Period | R&D Expense | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-30 | $10.46M | -36.89% | -20.46% |
| Q1 FY2026Period end 2026-03-31 | $16.57M | +15.86% | +113.63% |
| Q4 FY2025Period end 2025-12-31 | $14.30M | +4.09% | +77.36% |
| Q3 FY2025Period end 2025-09-30 | $13.74M | +4.50% | +237.93% |
| Q2 FY2025Period end 2025-06-30 | $13.14M | +69.50% | +226.26% |
| Q1 FY2025Period end 2025-03-31 | $7.75M | -3.81% | +542.50% |
| Q4 FY2024Period end 2024-12-31 | $8.06M | +98.33% | +424.53% |
| Q3 FY2024Period end 2024-09-30 | $4.07M | +0.89% | +321.68% |
| Q2 FY2024Period end 2024-06-30 | $4.03M | +233.80% | N/A |
| Q1 FY2024Period end 2024-03-31 | $1.21M | -21.47% | N/A |
| Q4 FY2023Period end 2023-12-31 | $1.54M | +59.44% | N/A |
| Q3 FY2023Period end 2023-09-30 | $964.00K | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
